Ownership history in MORGAN STANLEY · 25 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in D TITAN PHARMACEUT COM (TTNP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 2 | — | 0% | 0.00% | $10 | — |
| 2025 Q2 | REDUCED | 2 | -2 | -50.0% | 0.00% | $8 | — |
| 2025 Q1 | ADDED | 4 | +1 | +33.3% | 0.00% | $15 | — |
| 2024 Q4 | REDUCED | 3 | -1 | -25.0% | 0.00% | $10 | — |
| 2024 Q3 | ADDED | 4 | +1 | +33.3% | 0.00% | $21 | — |
| 2024 Q2 | UNCHANGED | 3 | — | 0% | 0.00% | $17 | — |
| 2024 Q1 | REDUCED | 3 | -15,497 | -100.0% | 0.00% | $21 | — |
| 2006 Q4 | REDUCED | 15,500 | -66,100 | -81.0% | 0.00% | $51K | — |
| 2006 Q2 | REDUCED | 81,600 | -117,500 | -59.0% | 0.00% | $175K | — |
| 2006 Q1 | ADDED | 199,100 | +78,800 | +65.5% | 0.00% | $671K | — |
As of 2025 Q4 — sorted by position size